Sign inGet started

Chapman Gina

Insider CIK 1989220 · TRDA Director · CRGX President & CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TRDA Entrada Therapeutics, Inc. A Award deriv2026-06-102026-06-1219,000— $019,000SEC↗
TRDA Entrada Therapeutics, Inc. A Award deriv2025-06-112025-06-1219,000— $019,000SEC↗
CRGX CARGO Therapeutics, Inc. A Award2025-03-142025-03-18200,000— $0303,905SEC↗
CRGX CARGO Therapeutics, Inc. M Exercise deriv2024-09-192024-09-202,975— $0549,515SEC↗
CRGX CARGO Therapeutics, Inc. S Sale2024-09-192024-09-202,975$25.03 $74.5K103,905SEC↗
CRGX CARGO Therapeutics, Inc. M Exercise2024-09-192024-09-202,975$5.03 $15.0K106,880SEC↗
CRGX CARGO Therapeutics, Inc. M Exercise deriv2024-09-182024-09-207,166— $0552,490SEC↗
CRGX CARGO Therapeutics, Inc. M Exercise2024-09-182024-09-207,166$5.03 $36.0K111,071SEC↗
CRGX CARGO Therapeutics, Inc. S Sale2024-09-182024-09-207,166$25.09 $179.8K103,905SEC↗
TRDA Entrada Therapeutics, Inc. A Award deriv2024-06-132024-06-1416,000— $016,000SEC↗
CRGX CARGO Therapeutics, Inc. A Award deriv2024-03-012024-03-04400,000— $0400,000SEC↗
TRDA Entrada Therapeutics, Inc. A Award deriv2023-09-012023-09-0532,000— $032,000SEC↗